Table of Contents Central Nervous System Disorders Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Central Nervous System Disorders Therapeutics 1.1 Central Nervous System Disorders Therapeutics Market Overview 1.1.1 Central Nervous System Disorders Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Central Nervous System Disorders Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Central Nervous System Disorders Therapeutics Market by Type 1.3.1 Global Central Nervous System Disorders Therapeutics Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type in 2018 1.3.3 Depression 1.3.4 MS 1.3.5 bipolar disorder 1.3.6 schizophrenia 1.3.7 epilepsy 1.3.8 AD 1.3.9 Parkinson' s 1.3.10 others 1.4 Central Nervous System Disorders Therapeutics Market by End Users/Application 1.4.1 Clinicals 1.4.2 Hospitials 2 Global Central Nervous System Disorders Therapeutics Competition Analysis by Players 2.1 Global Central Nervous System Disorders Therapeutics Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 Eli Lilly 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Central Nervous System Disorders Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 GlaxoSmithKline 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Central Nervous System Disorders Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Janssen Pharmaceuticals 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Central Nervous System Disorders Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Novartis 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Central Nervous System Disorders Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Pfizer 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Central Nervous System Disorders Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments ... 4 Global Central Nervous System Disorders Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) 4.2 Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Central Nervous System Disorders Therapeutics in Future 4.4 Top Consumer/End Users of Central Nervous System Disorders Therapeutics 5 North America Central Nervous System Disorders Therapeutics Development Status and Outlook 5.1 North America Central Nervous System Disorders Therapeutics Market Size (2014-2019) 5.2 North America Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 5.3 North America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 6 Europe Central Nervous System Disorders Therapeutics Development Status and Outlook 6.1 Europe Central Nervous System Disorders Therapeutics Market Size (2014-2019) 6.2 Europe Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 6.3 Europe Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 7 China Central Nervous System Disorders Therapeutics Development Status and Outlook 7.1 China Central Nervous System Disorders Therapeutics Market Size (2014-2019) 7.2 China Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 7.3 China Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 8 Rest of Asia Pacific Central Nervous System Disorders Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 9 Central & South America Central Nervous System Disorders Therapeutics Development Status and Outlook 9.1 Central & South America Central Nervous System Disorders Therapeutics Market Size (2014-2019) 9.2 Central & South America Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 10 Middle East & Africa Central Nervous System Disorders Therapeutics Development Status and Outlook 10.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Central Nervous System Disorders Therapeutics Market Size by Regions (2019-2025) 11.1.1 North America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Central Nervous System Disorders Therapeutics Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Central Nervous System Disorders Therapeutics Market Size (Million USD) Status and Outlook (2014-2025) Table Global Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Central Nervous System Disorders Therapeutics Market Share by Regions (2014-2019) Figure North America Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure China Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Central Nervous System Disorders Therapeutics Market Share by Type in 2018 & 2025 Figure Depression Market Size (Million USD) and Growth Rate (2014-2019) Figure MS Market Size (Million USD) and Growth Rate (2014-2019) Figure bipolar disorder Market Size (Million USD) and Growth Rate (2014-2019) Figure schizophrenia Market Size (Million USD) and Growth Rate (2014-2019) Figure epilepsy Market Size (Million USD) and Growth Rate (2014-2019) Figure AD Market Size (Million USD) and Growth Rate (2014-2019) Figure Parkinson' s Market Size (Million USD) and Growth Rate (2014-2019) Figure others Market Size (Million USD) and Growth Rate (2014-2019) Table Global Central Nervous System Disorders Therapeutics Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Central Nervous System Disorders Therapeutics Market Share by Application in 2018 & 2025 Figure Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate in Clinicals (2014-2019) Figure Central Nervous System Disorders Therapeutics Market Size (Million USD) and Growth Rate in Hospitials (2014-2019) Table Global Central Nervous System Disorders Therapeutics Revenue (Million US$) by Players (2014-2019) Table Global Central Nervous System Disorders Therapeutics Revenue Market Share by Players (2014-2019) Eigure Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table Global Central Nervous System Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Central Nervous System Disorders Therapeutics Market Share in 2018 Figure Global Top 10 Players Central Nervous System Disorders Therapeutics Market Share in 2018 Table Central Nervous System Disorders Therapeutics Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table Eli Lilly Basic Information List Table Eli Lilly Description and Business Overview Table Eli Lilly Central Nervous System Disorders Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Central Nervous System Disorders Therapeutics Business of Eli Lilly (2014-2019) Table Eli Lilly Central Nervous System Disorders Therapeutics Recent Developments Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Description and Business Overview Table GlaxoSmithKline Central Nervous System Disorders Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Central Nervous System Disorders Therapeutics Business of GlaxoSmithKline (2014-2019) Table GlaxoSmithKline Central Nervous System Disorders Therapeutics Recent Developments Table Janssen Pharmaceuticals Basic Information List Table Janssen Pharmaceuticals Description and Business Overview Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Central Nervous System Disorders Therapeutics Business of Janssen Pharmaceuticals (2014-2019) Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Recent Developments Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Central Nervous System Disorders Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Central Nervous System Disorders Therapeutics Business of Novartis (2014-2019) Table Novartis Central Nervous System Disorders Therapeutics Recent Developments Table Pfizer Basic Information List Table Pfizer Description and Business Overview Table Pfizer Central Nervous System Disorders Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Central Nervous System Disorders Therapeutics Business of Pfizer (2014-2019) Table Pfizer Central Nervous System Disorders Therapeutics Recent Developments Table Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type in 2018 Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Revenue Market by Application in 2018 Table Top Consumer/End Users of Central Nervous System Disorders Therapeutics Figure North America Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table North America Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure North America Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table North America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure North America Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure North America Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure Europe Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Europe Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table Europe Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Europe Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure Europe Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure China Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table China Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure China Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table China Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure China Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure China Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure Central & South America Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Central & South America Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Central & South America Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure Central & South America Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure Middle East & Africa Central Nervous System Disorders Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Central Nervous System Disorders Therapeutics Market Size Share by Players in 2018 Table Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Central Nervous System Disorders Therapeutics Market Size Share by Application in 2018 Figure Global Central Nervous System Disorders Therapeutics Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Size by Regions (2019-2025) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions in 2025 Figure North America Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) (Million USD) Figure Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size by Application in 2025 Table Global Central Nervous System Disorders Therapeutics Market Size by Type (2019-2025) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size by Type (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Eli Lilly GlaxoSmithKline Janssen Pharmaceuticals Novartis Pfizer